130 related articles for article (PubMed ID: 15769646)
41. Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development.
Ringelhan M; Heikenwalder M; Protzer U
Dig Dis; 2013; 31(1):138-51. PubMed ID: 23797136
[TBL] [Abstract][Full Text] [Related]
42. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms.
Bréchot C
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S56-61. PubMed ID: 15508104
[TBL] [Abstract][Full Text] [Related]
43. HBV suppresses ZHX2 expression to promote proliferation of HCC through miR-155 activation.
Song X; Tan S; Wu Z; Xu L; Wang Z; Xu Y; Wang T; Gao C; Gong Y; Liang X; Gao L; Spear BT; Ma C
Int J Cancer; 2018 Dec; 143(12):3120-3130. PubMed ID: 29752719
[TBL] [Abstract][Full Text] [Related]
44. HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway.
Zhu M; Li W; Lu Y; Dong X; Lin B; Chen Y; Zhang X; Guo J; Li M
Int J Cancer; 2017 Mar; 140(6):1346-1355. PubMed ID: 27925189
[TBL] [Abstract][Full Text] [Related]
45. [Relationship between hepatitis B virus X protein and hepatic cellular cancer].
Cai PP; Huang JW; Su CH; Cui XL; Xu RA
Yao Xue Xue Bao; 2016 Feb; 51(2):165-73. PubMed ID: 29856195
[TBL] [Abstract][Full Text] [Related]
46. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Gao F; Sun X; Wang L; Tang S; Yan C
Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974
[TBL] [Abstract][Full Text] [Related]
47. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
48. The molecular and pathophysiological implications of hepatitis B X antigen in chronic hepatitis B virus infection.
Martin-Vilchez S; Lara-Pezzi E; Trapero-Marugán M; Moreno-Otero R; Sanz-Cameno P
Rev Med Virol; 2011 Sep; 21(5):315-29. PubMed ID: 21755567
[TBL] [Abstract][Full Text] [Related]
49. The collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades.
Zhang R; Cao Y; Bai L; Zhu C; Li R; He H; Liu Y; Wu K; Liu F; Wu J
Mol Carcinog; 2015 Dec; 54(12):1554-66. PubMed ID: 25263696
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma.
Zhang B; Han S; Feng B; Chu X; Chen L; Wang R
Exp Mol Med; 2017 Feb; 49(2):e293. PubMed ID: 28186085
[TBL] [Abstract][Full Text] [Related]
51. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
Toyoda H; Kumada T; Kaneoka Y; Murakami Y
J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912
[TBL] [Abstract][Full Text] [Related]
52. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
53. Hepatitis B virus X gene differentially modulates cell cycle progression and apoptotic protein expression in hepatocyte versus hepatoma cell lines.
Yang CH; Cho M
J Viral Hepat; 2013 Jan; 20(1):50-8. PubMed ID: 23231084
[TBL] [Abstract][Full Text] [Related]
54. Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro.
Salpini R; Surdo M; Warner N; Cortese MF; Colledge D; Soppe S; Bellocchi MC; Armenia D; Carioti L; Continenza F; Di Carlo D; Saccomandi P; Mirabelli C; Pollicita M; Longo R; Romano S; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Iapadre N; Barlattani A; Bertoli A; Mari T; Pasquazzi C; Missale G; Sarrecchia C; Orecchini E; Michienzi A; Andreoni M; Francioso S; Angelico M; Verheyen J; Ceccherini-Silberstein F; Locarnini S; Perno CF; Svicher V
Oncotarget; 2017 Feb; 8(9):15704-15715. PubMed ID: 28152517
[TBL] [Abstract][Full Text] [Related]
55. Hepatitis B virus X protein co-activates pregnane X receptor to induce the cytochrome P450 3A4 enzyme, a potential implication in hepatocarcinogenesis.
Niu Y; Wu Z; Shen Q; Song J; Luo Q; You H; Shi G; Qin W
Dig Liver Dis; 2013 Dec; 45(12):1041-8. PubMed ID: 23891548
[TBL] [Abstract][Full Text] [Related]
56. [Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma and their significance in clinical settings].
Tong GD; Zhou DQ; He JS; Xiao CL; Liu XL; Zhou XZ; Zhang X; Xing YF; Lü P; Feitelson MA
Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):828-32. PubMed ID: 18073065
[TBL] [Abstract][Full Text] [Related]
57. The hepatitis B x antigen effector, URG7, blocks tumour necrosis factor alpha-mediated apoptosis by activation of phosphoinositol 3-kinase and beta-catenin.
Pan J; Lian Z; Wallet S; Feitelson MA
J Gen Virol; 2007 Dec; 88(Pt 12):3275-3285. PubMed ID: 18024896
[TBL] [Abstract][Full Text] [Related]
58. Oncogenic circuit constituted by Ser31-HBx and Akt increases risks of chronic hepatitis and hepatocellular carcinoma.
Lee WP; Lan KH; Li CP; Chao Y; Lin HC; Lee SD
Biochim Biophys Acta; 2016 Apr; 1862(4):837-849. PubMed ID: 26791804
[TBL] [Abstract][Full Text] [Related]
59. Pseudolaric acid B inhibits the secretion of hepatitis B virus.
Yu J; Wang Z; Ren P; Zhong T; Wang Y; Song F; Hou J; Yu X; Hua S
Oncol Rep; 2017 Jan; 37(1):519-525. PubMed ID: 27878296
[TBL] [Abstract][Full Text] [Related]
60. Molecular mechanisms of HBV-associated hepatocarcinogenesis.
Guerrieri F; Belloni L; Pediconi N; Levrero M
Semin Liver Dis; 2013 May; 33(2):147-56. PubMed ID: 23749671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
